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Application of "Click" Chemistry in Peptidomimetic Drug Design
Brian May and Dr. Shane Foister
May 2008

Abstract
The fonnation of a tetrazole ring from azide and nitrile derivatives are a simple method of
connecting two molecules together and have been noted as a novel method to create new drugs. The
creation of tetrazole linked sidechains from unnatural azide and nitrile amino acids are used to stabilize
secondary structure of proteins that are critical for biological interactions, specifically, the alpha helix and
the beta turn. After initial optimization through molecular modeling, the tetrazole linkage is applied to the
biological molecules cJun, an alpha helical homodimer involved in transcription, and Buforin II, an
antimicrobial peptide.

Introduction
Protein-protein interactions are the driving force behind biochemical pathways (I). Consequently,
it is very desirable to be able to control these interactions: Control offers potential understanding of the
mechanism of specific pathways as well as potential drug analogues that specifically can mediate how cell
interactions proceed. Over the course of the evolution of life, nature has made the complex systems that we
know today through a relatively small number, of small molecules, around 35 which are used to create
larger biological molecules (2). While much can be learned from modeling and manipulating the reactions
found in nature, it is also desirable to expand the "toolbox" the science can draw from in order control
molecular interactions. In attempting to bring diversity to chemical reactions that are biologically novel, it
is beneficial to find chemical reactions that are similar to those of nature: in their simplicity and ability to
fit the framework biological systems.
"Click" chemistry is one specific reaction that fulfills these desires. While "click" chemistry does
have a broad definition, this context involves the creation of a heterocyclic rings through the reaction of
two unsaturated heteroatom reactants. This specifically involves the reaction of alkynes and nitriles with
azide to create the hetero cyclic rings, triazoles and tetrazoles respectively, which react in the presence of a
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Figure 1: The mechanism of an azide and a nitrile click reaction results in either a cis-tetrazole or a
trans-tetrazole when catalyzed in water by a zinc salt or heat.

zinc catalyst or heat in water (3) (see Figure 1). Sharpless suggests that click is an ideal reaction for the
design of drugs for several reasons. First, the tetrazole linkage is a relatively small structure which is both
desirable for creating larger structures and not significantly altering surrounding structures (2). Second, the
reaction can be catalyzed in an aqueous solution through a relatively inert catalyst, or with not catalyst at all
in some instances, which allows reactions to take place in biological conditions. This relatively simple

reaction offers a whole host of new opportunities of the synthesis of new peptidomimetics that can control
the secondary structure of proteins.
The ability to selectively create a peptide with a secondary structure that is more stable than
normally found in nature leads to several pathways for drug design. A peptidomimetic with a more stable
structure could increase the efficiency of certain biological interactions as it more readily adopts the
optimal conformation needed for interaction. Alternatively, a peptidomimetic could be designed as a
competitive inhibitor, where specific sequences of a peptide that are important for interaction are kept, but
other sequences of the peptide important for activity are left out.
There are two different ways in which "click" linkage can be performed: On resin and in solution,
both of which are potentially novel. The term on resin refers to solid-phase peptide synthesis, in which one
end of the peptide is bound to a polymer resin. In this instance, the "click" reaction could be performed
while the peptide is still bound to the resin, cleaved, and then tested on a target. On resin linkage allows a

greater synthetic ease in making compounds and greater efficiency. In this method, delivering the peptide
to the target the conformation is locked into specific conformations. On the other hand, "click" performed
in solution, are perfonned after cleavage. This method of design is more useful for optimizing structures for
specific targets as it allows an on-target optimization. This in situ method allows the target to choose the
best fitting peptide sequence, as the peptide binds to the target and then "clicks" so that best choices are
selected by the target.
Not only is the alpha helix the most prominent secondary structure in proteins, but it also plays an
important role in the recognition of other proteins, consequently controlling protein interactions according
to a specific size, shape and sequence. Attempts to control these protein-protein interactions between these
surfaces have been made by creating smaller peptides that mimic these interactions (4). However, the utility
of these smaller peptide sequences have been underscored by the problem of the peptidomimetic becoming
denatured into a random coil instead of adopting the natural alpha helical structure that the peptide
sequence adopts in its natural state (5). This is a consequence of the smaller residues of the peptide yielding
a fewer number of intramolecular sidechain interactions and
hydrogen bonding backbone interactions that typically
stabilize the secondary structure of a peptide. With the loss
of secondary structure, the fragment no longer serves its
targeted function .
Therefore, it is desirable to create a way to stabilize the
alpha helical structure of these shorter peptide sequences in
order to maintain the designed mimic of the larger peptide in
question. Nature has provided the initial insight to solve this
problem, as an alpha helix is stabilized by a number of
different side chain interactions, such as electrostatics and
the hydrophobic effect (6)(See Figure 2).

Figure 2: Hydrophobic interactions between
nonpolar sidechains (left) stabilize an alpha
helix. Electrostatic interactions, as occur
between lysine and glutamate (right), also
stabilize an alpha helix.

To date, this has been done through creating a number
of different cyclic peptides, most notably hydrocarbon
stapling through ring closing metathesis, as well as lactam

and disulfide bridges (7,8,and 9). RCM is more significant because it is less susceptible to degradation
while other stabilizing linkers made from natural products are typically metabolized by in the cell (5).
Alpha-helical stabilization via tetrazole linkages would offer similar resistance to degradation as RCM,
since this ring is not typically found in nature biological systems.
All of the methods used to create sidechain linkages in peptides use a similar concept, which could also
be applied to click chemistry: An alpha helix consists of natural amino acids that create a turn of the helix
every 3.6 residues (5). This creates specific "faces" of the helix where amino acid side chains are in close
proximity. For example, the first residue, i, would be on the same face as the fourth and fifth residues, i+ 3
and i+4, as they constitute the next turn of the helix. Similarly, the eighth residue, i+7 would also be on
this same face, as it constitutes the second tum ofthe helix.
Since these side chains are in close proximity to each other, it is convenient to link these side-chains by
replacing the i residue's side chain with an azide group and the other residue: either i+ 3, i+4, or i+7.
However, in nature, all amino acids have the same stereochemistry of L, which becomes problematic when
attempting to link peptides because as one side chain faces the other, the other faces away. However, by
substituting one residue, i , with the enantiomeric D form of an amino acid, both sidechains face each other.
This enables side chain to interact and react with each other (See Figure 3).

Figure 3: Although placed on the same face of the helix, L-azide and L-nitrile amino acids are
oriented in the same direction, preventing a reaction from occurring (Left). Changing the Nterminus azide amino acid to the D form allows the two side chains to face each other and react

Other types of secondary structures are also promising in the ability to employ "click" chemistry
peptide design. Turns are a broad category variety of secondary structures that control how the other
secondary structures that they link are oriented. For example, the Beta hairpin allows beta stands to line up
into beta sheets in the anti parallel position .. The amino acid, proline, is noted as having a large role in turn
structures, particularly the beta hair pin. Proline is involved in turns and loops because its side chain forms
a ring structure with the amine backbone (6).
This structure locks proline into a very
specific conformation that is conducive to
turns. An amino acid derived from click that
could mimic the locked conformation that

Figure 4: The structural similarity between proline and a
potential mimic created from an unnatural amino acid
"clicked" to the backbone amine group.

proline has could enable turns to be
controlled (See figure 4).

Application of Click Chemistry in Real Systems
Inhibition of Alpha Helical Coiled-coil, c-Jun:
Activator Protein I (AP-l) is a transcription factor that plays an important role in several cellular
functions including cellular growth , differentiation, apoptosis and inflammatory response (10). Of
particular interest in the AP-I family are the proto-oncoproteins, Jun and Fos. Once dimerized, either as
Jun-JUll or JUll-Fos, these proteins create a binding site for DNA that allows transcription to occur (11).
When the regulation of these transcription factors are not controlled, undesired cell growth , cancer, occurs
(12).
These members of the basic-leucine zipper family (bZIP), Jun and Fos, are alpha helical proteins
that contain a basic domain necessary for DNA binding, and a leucine zipper domain that is responsible for
dimerization( 11). Alpha helical structures occur through a repeating seven residue pattern that describes a
specific peptide in relation to the position on the helix and are given the assignments: a, b, c, d, e, f, and g.
In this leucine zipper region, the leucine and other hydrophobic residues occupy the first and fourth
positions, a and d. Dimerization occurs as these hydrophobic sidechains are buried in the face of the two

helices interacting. Also, at the periphery of this leucine zipper, charged side chains form electrostatic
interactions between the two helices, further stabilizing the dimer (11).
Since transcription activity is dependent upon the dimerization of Jun-JUll or JUll-Fos, inhibition of
this interaction could prevent transcription and the proliferation of cancer cells. Several different
approaches have been taken in order to stop this interaction including a number of peptidomimetics as well
as non-peptide mimics (13,14). One strategy that has been used is to create a smaller peptide that mimics
the interaction at the leucine zipper region competitively inhibiting dimerization from occurring (14).
Unfortunately, these types of mimics in the past have proved less than desirable because of instability to
proteolysis and difficulty entering into biological membranes (12). A similar approach using a smaller
peptide with the addition of side chain cycIization through click chemistry could offer a more efficient
inhibition through increased
the binding affinity gained
from helix stabilization (See
Figure 5). This would also
create a drug less susceptible
to proteolysis via the unnatural
side chains.
A library consisting
of smaller adducts of the Jun
protein, stabilized through

Figure 5: A stabilized peptide mimic without the sequences
necessary for transcription could prevent Jun-Jun dimerizations as
the mimic- Jun interaction out competes the Jun-Jun interaction.

click could be made to
determine where to place the

side-chain link in order to get the optimal binding through in solution click. This could be monitored
through both circular dichroism, which would give an idea of the helicity of the small peptide, as well as a
fluorescence based assay developed by Daugherty and Gellman (1): The fluorophore, hydroxycoumarin
could be added to the tail of Jun as well as Fos. When added to solution alone, Jun would form a
homodimer, and ifFos was added aheterodimer would form. In either case, fluorophore would be
quenched by the neighboring fluorophore on other the Jun/Fos. However, if the small peptide was added

which competitively inhibited dimerization from occurring, the fluorophore would no longer be quenched,
resulting in fluorescence , which could be indicate binding affinity of the fragments

The strengthening of Anti-microbial drugs: Buforin II
In recent years, a number of different novel antimicrobial drug have been discovered from nature.
Of interest with respect to the application of click chemistry are a group of pep tides relatively short (less
than 40 A.A.) include a number alpha -helical peptides: cerrecropins from silk moths, melletins from
honey bee venom, and buforins from the Asian toad, Bufo bufo garagrizans, (15 , 16) Since the latter
consists of two novel applications for click chemistry, it will initially be examined in the context of these
types of antimicrobials, although more could certainly be studied.
Buforin II is a 21 A.A, peptide that demonstrates a significant antimicrobial activity among a wide
range of microbes (16). While the mechanism is not exactly known , this type of antimicrobial enters into
the cell and binds to nucleic acids, which prevent cell replication. Its structure is a helix-hinge-helix, where
the N-terminal helix is formed by residues 5 to 10, the C-terminal residue helix consisting of residues 12 to
21, both of which are connected by a proline hinge (17). Park et al. have determined that several factors
play an important role in the peptide ' s antimicrobial activity. First, alpha helicity correlates linearly with
activity. Therefore, using click chemistry to stabilize the two alpha helices could increase potency. Second,
the activity of the peptide is also dependent on the proline hinge in order to penetrate the cell (16) . Cell
permeability could be increased through the replacement of the proline in this sequence with mimic that is
more conformationally fixed "clicked" residue (as seen Figure 4) .

Experimental Methods
Molecular Modeling
Energy minimizations and calculations performed using in Spartan software were carried out using
the MMFF94aq force field .
Minimizations in Sybyl 8.0 were performed using a Powell Gradient of 0.05 KcaVmol* A with an
initial optimization using the Simplex Method with a cutoff set at 1000 iterations. The force field used was
MMFF94s and energy charge used was MMFF94. The backbone of the peptide was locked using the
AGGREGATES function.

Synthesis Unnatural Amino Acid Synthesis
Unnatural amino acids that are required from click chemistry were created from a number of
commercially available precursors (See Fig. 6). The scheme of amino acids with different side chain alkyl
spacers that can be clicked are generally the same, but in this case, synthesis is shown of clickable side
chains with a two carbon chain linking the groups to the backbone.

Azide Synthesis
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Figure 6: A general scheme for the synthesis of the D-azide and L-Nitrile unnatural amino acids

Azide Amino Acid Synthesis
Butoxycarbonyl

moC) Protection of D-glutamine:

First, the commercially available unnatural amino acid, D- glutamine was placed in a solution of 10%
potassium bicarbonate. At O°C, 1.2 equivalents of di-tert-butyldicarbonate were added in a solution of the
minimal amount of acetonitrile needed to dissolve the reagent. Then, the solution was brought to room
temperature and left to reaction for around 5 hours. The reaction was monitored by Thin Layer
Chromatography (TLC). After the reaction was determined to be complete, it was cooled again to O°C and
acidified to a pH 2 using 1M HC!. The product was extracted from the aqueous phase using a three washes
diethyl ether. The solvent was removed in vacuo.

Conversion of Boc-glutamineCt-Butoxycarbonvl-(2Ri-2-amino-4-carbamoyl-butanoic acid) to an amine
side chain Ct-Butoxycarbonyl-(2Ri-2 4-diamino-butanoic acid):
The Boc-glutamine was dissolved in a solution of 3 ethyl acetate: 3 acetonitrile: I water and cooled to
O°c. Iodobenzenediacetate was added at 1.2 equivalents and left to stir 30 minutes, and left to react for
around 4 hours . The reaction was monitored using TLC. After the reaction was complete, the solvent was
removed in vacuo. A small amount of ethyl acetate was added to the reagents and the solution was cooled
to O°C. The precipitated product was collected by filtration.

Conversion of t-Butoxycarbonyl-(2R)-2.4-diamino-butanoic acid to t-Butoxycarbonyl-(2Ri-2 amino 4azide-butanoic acid:
The reagent was dissolved in the water and .01 molar equivalents of Zinc Chloride were added as well
as 4 molar equivalents of triethylamine were added. The reaction was cooled to O°C and 4 molar
equivalents of freshly prepared triflic azide was added as a I M solution in dichloromethane. The reaction
was brought to room temperature and left to react for around 5 hours. The reaction was monitored via TLC.
Once the reaction had completed, the organic solvent was removed in vacuo and the aqueous phase was
cooled to O°C and acidified to pH 2 using 1M HC!. The product was extracted through diethyl ether rinse
(3X).

Removal ofBoc group and FmocC9H-fluoren-9-ylmethoxycarbonyl) Protection:
The Boc group was removed in a solution of 80% Triflouroaceticacid in DCM for about I hour and
was monitored by TLC. Then, the unprotected amino acid was placed in a solution of 10% weight by
volume Potassium Carbonate in water. A solution of three equivalents of 9H-fluoren-9ylmethoxycarbonylsuccinimide dissolved in minimal amount of acetonitrile was added to the solution at
O°C. After 30 minutes the reaction was brought to room temperature and left to run for 3-4 hours as
monitored by TLC. It should be noted that running the reaction any longer than 5 hours results in a
breakdown of the product. The solution was acidified to pH 2 using HCI. The product was extracted from
the aqueous layer through a diethyl ether wash (3x). The solvent was removed in vacuo.
The fmal product was purified by flash column chromatography.

Nitrile Amino Acid Synthesis

Conversion of t-ButoxycarbonyH2S)-2-amino-4-carbamoyl-butanoic acid to t-Butoxycarbonyl-C2R)-2amino-4-cyano-butanoic acid:

Commercially available Boc-L-glutamine was dissolved in a solution of acetic anhydride and cooled to
O°c. Then, 1.2 equivalents of pyridine were added and the reaction was brought to room temperature and
left to react for around 5 hours. The reaction was monitored by TLC. Once the reaction had completed,
acetic anhydride was removed in vacuo, and DCM was added to the solution. Then organic layer was
washed twice with an acetic acid rinse and twice with water in order to get rid of bypro ducts and unreacted
starting material. Sodium sulfate was used to dry the organic layer and t he solvent was removed.

Deprotection of Boc group and Fmoc protection of 2R)-2-amino-4-cyano-butanoic acid:
The Boc group was removed in a solution of 80% Trtflouroaceticacid in DCM for about I hour and
was monitored by TLC. Then, the unprotected amino acid was placed in a solution of 10% weight by
volume Potassium Carbonate in water. A solution of three equivalents of 9H-fluoren-9ylmethoxycarbonylsuccinimide dissolved in minimal amount of acetonitrile was added to the solution at
O°C. After 30 minutes the reaction was brought to room temperature and left to run for 3-4 hours as
monitored by TLC. It should be noted that running the reaction any longer than 5 hours results in a

breakdown of the product. The solution was acidified to pH 2 using HC\. The product was extracted from
the aqueous layer through a diethyl ether wash (3x). The solvent was removed in vacuo.
The final product was purified by flash column chromatography.

Peptide Synthesis
The pep tides synthesize were made through solid phase peptide synthesis on commercially available Rink
resin. In the addition of each amino acid monomer, the procedure was followed:
Cleavage of Protecting Group
The Fmoc group was removed form the resin by adding 25% piperidine/ in N-methyl pyridine, first for 0.5
minutes, and then repeating this step allowing the piperidine to react for 15 minutes. The resin beads were
washed with DMF twice and then DCM twice.
Amino Acid Coupling
The coupling solution was created through the addition of 3 equivalents of the amino acid, 6 equivalents of
DIEA(diisopropylethyJamine), and diluting the solution with NMP, N-methyl pyridine, so that [Amino
Acid] > 0.2 M. Then, 2.95 equivalents of HBTU, O-Benzotriazole-N,N,N' ,N' -tetramethyl-uroniumhexafluoro-phosphate, and I equivalent ofHOBt, N-Hydroxybenzotriazole, were added to the solution.
During the addition of unnatural amino acids, HCTU, O-Benzotriazole-N,N,N',N'-tetramethyl-uroniumhexafluoro-phosphate, was used in place of HBTU. The mixture was shaken for at least 10 minutes and was
squirted onto the resin. The coupling reaction was left for 1-2 hours. The completion of the reaction was
determined through a Kaiser Test to check for a free amine after washing the resin with DMF twice and
DCM twice.
For each monomer, these steps were repeated. Occasional changes in procedure were made
according to the Novabiochem procedure for peptide synthesis, which also provided these guidelines for
peptide synthesis (18).

Purification of Peptides
Peptides were purified by a Beckman Coulter Reverse Phase HPLC on a Varian C-18 column with a
solution gradient of 95% 0.1 %TFAI H 20: 5 % Acetonitrile to 5% 0.1 %TFAI H 20: 95 % Acetonitrile.

Characterization of compounds:
Peptides were characterized through MADLI mass spectrometry. Amino acids were characterized through
Proton NMR, C 13 NMR, and Electron Spray mass spectrometry.

Experimental Results, and Discussion
As previously mentioned, the ability to "click" to side

chains together depends on their orientation and ability to
access each other in a way that does not require a great
amount of energy. Essentially, this depends upon to two
factors: residue position and side chain length. Rather than
attempting to create a library of all potential residues,
Control peptide chain

molecular modeling software, Spartan, was using to
simulate the library of potential clickable side chains.
First, a seven alanine residue peptide (eleven for the
i, i + 7 linkages) was built, specifying that it was to be in the
;, ;+3 cis-tetrazole linkage

alpha helical conformation. The energy of the peptide was
minimized and the backbone of the peptide was locked in
place. The library was built by creating the tetrazole
linkages, both potential cis and trans linkages with the
azide end being at the i position and the nitrile being at the
i+x position, i+ 3, i+4, i+7. For each of these positions,

;, ;+3 cis-alkene linkage

the chain length of the side chain linker was varied at both

Figure 8: A sample of molecules
considered in calculations comparison
between linkages.

the i and i+x ends. Also, to give context to the types of
energies that were being produced, calculations were also
performed in the same manner for ring closing metathesis.

i, i+3 Tetrazole Linkage Energy
Trans
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E
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E

·20n.08
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dE

1.61
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i, i+4 Tetrazole Linkage Energy
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Solvent
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E

-1806.54

dE

56.44

23.09

-2080.14

-2105.94

-1045

-27.25

(v5.comroi)

E

Water

Cis

-m3.19

dE
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Alkene Linkage Energy (ReM)
Trans
I

~

E
Chloroform

Alkyl

-2892.43

-2874.08

-2887.89

-20,42

-2.06978

-15.88

-340855

-3355.53

-3367.83

1652

6954

57.23

dE
1... 5. control)

Water

Cis

E
dE
(vs. control)

* All Energies are in kJ/mol.

Table 1: Energies of "clicked" tetrazole linkages compared to that of ReM.
These initial calculations provided good insight to the potential linkages that would result in a
cyclized peptide and the stabilization of an alpha helix. Noteworthy structures and energy values have been
included in Table 1. The calculations have indicated that there a number of potential structures that could
stabilize an alpha helix as indicated by the negative

~

values compared with the control structure. The

best of all linkages was that of the two alkyl chain spacer in both side chains of the tetrazole linkage at the
i,i+ 3 positions. In fact, the i,i+ 3 position showed a large number of possible linkages of different lengths
that could induce stabilization. This is likely a simple function of the orientations of the side chains toward
each other as well as the conformations of the tetrazole ring itself, particularly in the cis conformation. In
light of these factors, the linkage has an easier time fitting the desired bond angle of the side chain C-alpha
carbons on the backbone. However, the i, i+4 position does also yield some linkages that could be novel in

their use, such as a linkage with a three alkyl chain spacer at the i position and a 2 alkyl chain spacer at the
i+4 positions. The multiple positions for linkage are very beneficial as it gives multiple options when
considering where to place linkages in a real biological structure. In nature, side chain can often have a
significant impact on structure or activity. Being able to choose from two different spacings ,i, i+ 3 and i,

i+4, affords the ability to work around specific instances where a sidechain is important and cannot be
replaced, especially in smaller molecules like Buforin II where options for placement are limited.
Also, many of the calculated energies for
these potential linkages are much lower than
cJun Homodlmer Energy

similar linkages that have been performed

Cis-Diethyl Tetrazole Linkage at i, i+3 Position
iPosltion

E
IKcal/moll

Control

-853.02

experimentally through ReM. This indicates

E
(vs. control)

that not only that the calculated valuable are

G-275

-861.49

-8.47

A-278

-679.89

173.13

R-279

-564.45

288.56

E-282

-703.42

149.60

K-285

-842.22

10.80

T-286

-890.96

-37.94

A-289

-893.73

-40.71

Q-290

-712.45

140.57

S-292

-859.76

-6.74

E-293

-773.85

79.17

5-296

-819.66

33.37

T-297

-876.89

-23.87

N-299

-611.84

241.18

M-300

-759.60

93.42

E-303

-753.77

99.25

Q-304

-816.40

36.62

A-306

-877.08

-24.06

reasonable, they also have the potential to
stabilize an alpha helix better than similar
methods. This could promise to allow for
much more efficiency in the context of
competitive inhibition.
After the initial calculations provided
insight to the best kind of linkage, this
concept could be placed in a real peptide,
which was chosen as cJun molecule. For the
application of the tetrazole linker on the Jun
dimer it was also necessary to examine the

For cJun Sequence:

interactions between the Jun-Jun and Jun-Fos
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273
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I
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Table 2: The energies of a tetrazole linkage at
different locations along the helix give a
preliminary indication of possible peptide mimics.

dimers in order to determine where not to
place the tetrazole linker. If the linker was
placed at a residue that was normally critical to
stabilization of the dimmer, or in the leucine

zipper face, this could potentially prevent the small peptide from binding to the target, Jun.
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software. Once, the dimer has
undergone energy minimization, the
backbone of each helix was locked in
place, and a library of tetrazole

1.52
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1.56

linkers was created by walking the
linkers down the peptide, performing
energy minimization calculations at
each step (See Table 2). The leucine
zipper region was avoided in this
library, so only the side-chains in the

1.85

solvent exposed face of the dimer
were used to create the linker.
2.64

Figure 5: A helical wheel diagram of Jun-Jun homodimer
and Jun-Fos heterodimers with prominent interactions
between sidechains express as dashed lanes along with the
distance (in Angstroms) between interacting groups.
Distances are only shown on one side of Jun homodimer as
the other side involves the same distances. H-bonding and
electrostatic groups are shown in red, hydrophobic groups
in green and others in yellow.

Additionally, both the cJun
homodimer and the JUll-Fos
heterodimer, also obtained from the
Protein Databank (20), were used in
Sybyl 8.0 to calculate the distance
between potential electrostatic and

hydrogen bonding atoms that would stabilize the two peptides and therefore not be beneficial to
replace.(See Figure 5).

The energy calculations for the tetrazole Jun mimic agree with the energies represented in the wheel
diagram. From the initial calculations, candidates for tetrazole linkages are where i equals G-275, T-286,
A-289, T-297, and A-306. However, G-275 is less important as it is on the end of the helix and not
involved in the leucine zipper region, where dimerization occurs. Considering the Jun-Fos interactions
represented, T-286, A-289, A-309 are the best choices as they are not involved in any dimer stabilizing
interactions. Therefore, these two locations should be the starting point for any mimics that is created for
the Jun molecule.
The proline turn mimic was also optimized by creating a library consisting of the tetrazole with
varying chain lengths, from 5 carbons to 1 on each side, attached to the C-alpha and the amine backbone.
The, calculations were performed for both potential cis and trans conformations of the tetrazole, as well as
using both D and L enantiomers of the amino acid. Calculations were performed in two different ways:
First, the three peptide turn sequence of glycine-proline-glycine was created. The energy of the sequence
was minimized using the same parameters as in previous calculations. Then, the backbone was frozen, and
each molecule in the library was created using the three sequence backbone as a template and minimized.
Energy minimizations were performed the same library again, but without the locked backbone. In addition
to energy minimizations, the distance between both the hydrogen bonding N terminus amine of the glycine
at residue 1 and the C terminus carbonyl group of the glycine at residue 3 as well as the distance between
the side chains of the two glycine residues were taken for each member of the library. Results from the
calculations can be seen in Table 3.
The results indicate that the L form amino acids are consistently lower in energy than the D-form. This is
likely due to the fact that in nature, proline is in the L from and it is easier to have an amino acid with the
same chirality act similarly. Of these amino acids, the mimics with shorter chain lengths are more stable

Cyclic "Clicked" Amino Acid Proline Mimics

Table 3: The data represents the D and L forms of the amino acid where the energy values are
the lower of the cis and trans conformations. Since the backbone was locked in the L form of
proline, the energies of the D- linkage in this form were extremely unreasonable and therefore not
used as seen by XXX.
and will likely provide significantly more rigidity than the proline since the calculated energy is so much.
lower, around 30Kcal/mol When synthesizing these mimics it would be best to begin with a tetrazole
linkage with one alkyl group spacer on the C-alpha carbon and a two alkyl group spacer to the amine
backbone. While the a tetrazole with one alkyl groups spacers between both sides of the backbone is more
energetically favorable, the synthesis of this amino acid is significantly more difficult as the precursors are
unstable.

Peptide Design
Initial Test Sequence
The basis of the entire concept of the stabilization of secondary structure through "click" chemistry
relies on the ability for an azide and a nitrile to react in a peptide. Therefore, it was necessary to ensure that
"click" chemistry works in this context. A simple peptide with sequence XP AZ was made where X was the
glutamine-derived azide and Z was the glutamine-derived nitrile. A click reaction was performed on this
sequence both on-resin and in solution. Characterization through HPLC indicates that the peptide did react
as it had a different retention time as the unclick reactant,. Further characterization through mass
spectrometry showed the same mass as the unclicked peptide. The combination of an altered retention time
of the peptide with the retention of
its original mass indicates that

Buforin II Peptide Sequences
Control TRSSRAGLQFPVGRVHRLLRK
TRSXRAZLQFPVGRVHRLLRK
1
TRSXRAGZQFPVGRVHRLLRK
2
TRSSRAGLQFPVGRXHRZLRK
3
TRSSRAGLQFPVGRXHRLZRK
4
TRSXRAZLQF VGRXHRZLRK
5
TRSXRAGZQF VGRXHRLZRK
6
N3

X=
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...OH
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tetrazole linkages can be made in
pep tides using modified amino acids.

Buforin II
The Buforin II molecule
has two alpha-helixes in its structure,
both of which are of interest. For this
reason, various different peptide
derivates were created at the location
of both helixes as seen in Figure 7.
At this time, the project is still in

OH

0

this phase.

Figure 10: Buforin II sequences with "Oickable"
sidechains.

Conclusions
The potential for "click" chemistry to be integrated into natural peptide sequences to create
peptidomimetics with stabilized secondary structures has been explored. The ability to control secondary

structure allows the ability to stabilize or inhibit many different kinds of interactions that occur between
proteins. Molecular modeling has indicated that creating a tetrazole ring from azide and nitrile side chains
will stabilize an alpha helix using several specific side chains lengths both at i,i+ 3 and i,i+4. In fact,
according to the free energy of the modeled molecule, the effects will be much greater than other similar
side chain linkages such as RCM. Molecular modeling was also performed to find the optimized tetrazole
linkage that could create an unnatural amino acid with a fixed conformation that could induce a turn,
similar to proline.
A legitimate scheme for creating these unnatural amino acids for peptide synthesis has also been
established and refined. Through integrating these monomers into a small peptide, the ability for to create a
tetrazole ring from the azide and nitrile side chains has been confirmed. Additionally, the chemistry works
both on resin and in solution. This yields the ability to create assays for on target drug design via "click" in
solution as well as have a reliable and high yield method to create a specific peptide once it has been
optimized.
This preliminary data is very promising toward possible applications for drug design. As modeling
shows that the underlying concept of the project has a solid basis, the confirmed ability to create these type
of peptides indicates that the project is novel. In order to test this concept in an actual peptide, two different
sequences with different applications were selected: cJun and Buforin II. Since, cJun is such a large
molecule, molecular modeling was used to determine where tetrazole linkages would be best. Since
Buforin had limited options as far as the placement of a tetrazole linkages, no calculations were performed.
However, since the peptide is short, it is synthetically much easier to make than Jun so it was chosen as the
first peptide to test.

Future Work
The process of performing calculations, creating unnatural amino acids and then creating actual
peptides has been very time intensive and for that reason there is much to be finished. Buforin peptides,
once synthesized, will need to be tested for helicity through circular dichroism and tested against E. Coli
strains for their effectiveness in killing bacterial cells as compared to the control Buforin II. Also, a Buforin
II peptide mimic with the tetrazole cyclized amino acid replacing the proline hinge needs to be created and
tested in the same manner.

In the application of 'click" chemistry in the lun molecule, peptides need to be synthesized with
the unnatural azide and nitrile amino acids using the modeling and energy diagrams as a basis for choosing
sequences. Using in solution "click", the helicity can be determined through circular dichroism.
Additionally, in solution click with also be employed with the lUll peptide mimic in an assay of lun and Fos
proteins with fluorescent tags attached to determine which sequences can best interrupt both the cJun
homodimer and the Jun- Fos interactions. Once these interactions are established, the ability of the mimic
to inhibit transcription in a live cell culture can be determined.
Also, the application of "click" chemistry in the stabilization of another secondary structure, the
beta sheet needs to be examined. Just as side chain cyc1ization in an alpha helix can occur, side chain
cyclization of to stabilize two anti parallel beta sheets could also open another avenue for drug design.
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